Skip to main content
Log in

Genetic Counseling, Activism and ‘Genotype-First’ Diagnosis of Developmental Disorders

  • Published:
Journal of Genetic Counseling

Abstract

This paper presents a sociological examination of the role of genetic counselors as advocates, not only for patients and their families, but also for genetic conditions themselves. In becoming activists for new disorders, genetic counselors are helping to create new categories that will shape expectations and treatment regimens for both existing patients and those who are yet to be diagnosed. By virtue of their expertise and their position at the intersection of several key professions and constituencies, genetic counselors are likely to play a central role in the way the genetic testing technologies, and especially ‘genotype-first’ diagnosis, impacts the way we understand and categorize developmental difference. I outline some of the promises and dangers that this kind of activism holds for people with developmental disabilities, and particularly the challenge presented by systemic ascertainment bias in the face of genotype-phenotype uncertainty. I argue that new testing techniques like microarray analysis that do not need to be targeted on the basis of clinical presentation throw these challenges into sharp relief, and that the genetic counseling community should consider how to marry advocacy for new genetic conditions with an emphasis on the indeterminate developmental potential of every child.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aronowitz, R. A. (1999). Making sense of illness: Science, society and disease. Cambridge University Press.

  • Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, A., et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. The Journal of Pediatrics, 159(2), 332.e1–339.e1.

    Article  Google Scholar 

  • Beckwith, J. (1972). Science for the people. Annals of the New York Academy of Sciences, 196(4), 236–240.

    Article  PubMed  CAS  Google Scholar 

  • Bosk, C. L. (1992). All God’s mistakes: Genetic counseling in a pediatric hospital (1st ed.). University Of Chicago Press.

  • Bretelle, F., Beyer, L., Pellissier, M. C., Missirian, C., Sigaudy, S., Gamerre, M., et al. (2010). Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. European Journal of Medical Genetics, 53(6), 367–370.

    Article  PubMed  Google Scholar 

  • Brown, A., Phelan, M. C., Patil, S., Crawford, E., Rogers, R. C., & Schwartz, C. (1996). Two patients with duplication of 17p11.2: The reciprocal of the Smith-Magenis syndrome deletion? American Journal of Medical Genetics, 63(2), 373–377.

    Article  PubMed  CAS  Google Scholar 

  • Costain, G., Chow, E. W. C., Ray, P. N., & Bassett, A. S. (2012). Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. Journal of Intellectual Disability Research.

  • Deak, K. L., Horn, S. R., & Rehder, C. W. (2011). The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: Variable expressivity and genomic complexity. Clinics in Laboratory Medicine, 31(4), 543–564.

    Article  PubMed  Google Scholar 

  • Driscoll, D. A., Spinner, N. B., Budarf, M. L., McDonald-McGinn, D. M., Zackai, E. H., Goldberg, R. B., et al. (1992). Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. American Journal of Medical Genetics, 44(2), 261–268.

    Article  PubMed  CAS  Google Scholar 

  • Finucane, B. (2011). 2012 National society of genetic counselors presidential address: Maintaining our professional identity in an ever-expanding genetics universe. Journal of Genetic Counseling, 21(1), 3–6.

    Article  PubMed  Google Scholar 

  • Finucane, B., Haas-Givler, B., & Simon, E. W. (2003). Genetics, mental retardation, and the forging of new alliances. American Journal of Medical Genetics, 117C(1), 66–72.

    Article  PubMed  Google Scholar 

  • Greenberg, F., Lewis, R. A., Potocki, L., Glaze, D., Parke, J., Killian, J., et al. (1996). Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). American Journal of Medical Genetics, 62(3), 247–254.

    Article  PubMed  CAS  Google Scholar 

  • Gropman, A. L., Duncan, W. C., & Smith, A. C. M. (2006). Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatric Neurology, 34(5), 337–350.

    Article  PubMed  Google Scholar 

  • Heath, D., Rapp, R., & Taussig, K. (2004). Genetic citizenship. A Companion to the anthropology of politics. Blackwell.

  • Jacobs, P. A., Brunton, M., Melville, M. M., Brittain, R. P., & Mcclemont, W. F. (1965). Aggressive behaviour, mental sub-normality and the XYY male. Nature, 208(5017), 1351–1352.

    Article  PubMed  CAS  Google Scholar 

  • Larson, R. S., & Butler, M. G. (1995). Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases. Diagnostic Molecular Pathology: The American Journal of Surgical Pathology, Part B, 4(4), 274–278.

    Article  CAS  Google Scholar 

  • Ledbetter, D. H. (2008). Cytogenetic technology – genotype and phenotype. New England Journal of Medicine, 359(16), 1728–1730.

    Article  PubMed  CAS  Google Scholar 

  • Lippmann, A. (1991). The geneticization of health and illness: Implications for social practice. Endocrinologie, 29(1–2), 85–90.

    PubMed  CAS  Google Scholar 

  • McDonald-McGinn, D. M., & Zackai, E. H. (2008). Genetic counseling for the 22q11.2 deletion. Development Diabilities Research Reviews, 14(1), 69–74.

    Article  Google Scholar 

  • McDonald-McGinn, D. M., Zackai, E. H., & Low, D. (1997). What’s in a name? The 22q11.2 deletion. American Journal of Medical Genetics, 72(2), 247–249.

    Article  PubMed  CAS  Google Scholar 

  • McDonald-McGinn, D. M., Kirschner, R., Goldmuntz, E., Sullivan, K., Eicher, P., Gerdes, M., et al. (1999). The Philadelphia story: The 22q11.2 deletion: report on 250 patients. Genetic Counseling (Geneva, Switzerland), 10(1), 11–24.

    CAS  Google Scholar 

  • McDonald-McGinn, D. M., Tonnesen, M. K., Laufer-Cahana, A., Finucane, B., Driscoll, D. A., Emanuel, B. S., et al. (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! Genetics in Medicine: Official Journal of the American College of Medical Genetics, 3, 23–29.

    Article  CAS  Google Scholar 

  • Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies, 86(5), 749–764.

  • Navon, D. (2011). Genomic designation: How genetics can delineate new, phenotypically diffuse medical categories. Social Studies of Science, 41(2), 203–226.

    Article  PubMed  Google Scholar 

  • NSGC.org. (2012a). FAQ’s/Definitions. Retrieved February 13, 2012, from http://www.nsgc.org/About/FAQsDefinitions/tabid/97/Default.aspx

  • NSGC.org. (2012b). FAQs about Genetic Counselors and the NSGC. Retrieved February 13, 2012, from: http://www.nsgc.org/About/FAQsaboutGeneticCounselorsandtheNSGC/tabid/143/Default.aspx

  • Phelan, M. C. (2011). Interview, March 4th 2011, New York NY.

  • Phelan, M. C., Rogers, R. C., & Stevenson, R. E. (1988). A de novo terminal deletion of 22q. American Journal Of Human Genetics, 43, A118.

    Google Scholar 

  • Phelan, M. C., Rogers, R. C., Saul, R. A., Stapleton, G. A., Sweet, K., McDermid, H., et al. (2001). 22q13 deletion syndrome. American Journal of Medical Genetics, 101(2), 91–99.

    Article  PubMed  CAS  Google Scholar 

  • Potocki, L., Bi, W., Treadwell-Deering, D., Carvalho, C. M. B., Eifert, A., Friedman, E. M., et al. (2007). Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. American Journal of Human Genetics, 80(4), 633–649.

    Article  PubMed  CAS  Google Scholar 

  • Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Estabrooks Hahn, S., Strecker, M. N., et al. (2006). A new definition of genetic counseling: National society of genetic counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83.

    Article  PubMed  Google Scholar 

  • Shaffer, L. G., Bejjani, B. A., Torchia, B., Kirkpatrick, S., Coppinger, J., & Ballif, B. C. (2007). The identification of microdeletion syndromes and other chromosome abnormalities: Cytogenetic methods of the past, new technologies for the future. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C(4), 335–345.

    Article  Google Scholar 

  • Shaffer, L. G., Coppinger, J., Morton, S. A., Alliman, S., Burleson, J., Traylor, R., et al. (2011). The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenatal Diagnosis, 31(8), 778–787.

    Article  PubMed  CAS  Google Scholar 

  • Smith, A. C., Dykens, E., & Greenberg, F. (1998). Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2. American Journal of Medical Genetics, 81(2), 179–185.

    Article  PubMed  CAS  Google Scholar 

  • Smith, A. C. M., Gropman, A. L., Bailey-Wilson, J. E., Goker-Alpan, O., Elsea, S. H., Blancato, J., Lupski, J. R., et al. (2002). Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genetics in Medicine: Official Journal of the American College of Medical Genetics, 4(3), 118–125.

    Article  CAS  Google Scholar 

  • Terry, S. F., Terry, P. F., Rauen, K. A., Uitto, J., & Bercovitch, L. G. (2007). Advocacy groups as research organizations: The PXE International example. Nature Reviews Genetics, 8(2), 157–164.

    Article  PubMed  CAS  Google Scholar 

  • Veltman, J. A., & Brunner, H. G. (2010). Understanding variable expressivity in microdeletion syndromes. Nature Genetics, 42(3), 192–193.

    Article  PubMed  CAS  Google Scholar 

  • Verkerk, A., Pieretti, M., Sutcliffe, J., Fu, Y., Kuhl, D., Pizzuti, A., et al. (1991). Identification of A Gene (Fmr-1) containing A Cgg Repeat coincident with a breakpoint cluster region exhibiting length variation in fragile-X syndrome. Cell, 65(5), 905–914.

    Article  PubMed  CAS  Google Scholar 

  • Whitmarsh, I., Davis, A. M., Skinner, D., & Bailey, D. B. (2007). A place for genetic uncertainty: Parents valuing an unknown in the meaning of disease. Social Science & Medicine, 65(6), 1082–1093.

    Article  Google Scholar 

Download references

Acknowledgments

I am grateful for invaluable feedback from Peter Bearman, Claire Edington and Gil Eyal and the generous support of the USA-Israel Binational Science Foundation, grant number 2010175.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Navon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navon, D. Genetic Counseling, Activism and ‘Genotype-First’ Diagnosis of Developmental Disorders. J Genet Counsel 21, 770–776 (2012). https://doi.org/10.1007/s10897-012-9515-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-012-9515-9

Keywords

Navigation